Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question for our Board Lawyers

Question for our Board Lawyers

posted on Nov 25, 2007 05:52PM

It seems logical to me that the resolution of the litigation with the J3 will be license deals with all three, each for the entire MMP. In my opinion, those license deals would be predicated on and would only go into effect upon the dismissal of the lawsuits by TPL/PTSC. The dismissal would be of the type that would prevent them from being refiled (dismissal with prejudice I believe).

This would accomplish all the things that TPL/PTSC wants, in that they get a positive resolution to the litigation thru settlement, they open the door to all the future license deals, plus this is a face saving scenario for the J3 in that they don't lose a case and instead make a business deal. Obviously, for this to be the ultimate positve result for TPL/PTSC, the license fees have to be significant enough to validate the process and deter others from holding out (I think $50M per defendant MINIMUM and preferably at least $75M).

My question is whether this seems like a likely legal resolution process in a case like this and if this were to happen, would the Court require anything but a filing for the dismissal to finalize this?

Share
New Message
Please login to post a reply